乌鸦传媒

Triptans are efficacious and underused, researchers say

Investigational Lu AG09222 met primary end point in proof-of-concept trial

But not everyone can reliably identify prodrome events, notes expert

At 48 weeks, atogepant showed consistent safety profile and efficacy

Headache episodes during long space travel more common than previously thought

Acute migraine drugs raised ischemic event odds for people with underlying risk factors

Anxiety, depression, stress as headache predictors were superseded by sleep changes

Physical isolation and lack of specialty care may play a role

Imaging links inflammation to migraine and tension headaches

Researchers compared headache diary data before and after vaccination or infection

Gepant reduced number of monthly migraine days

Findings may influence treatment approaches for some patients

Awareness of sex differences in symptoms, triggers may increase diagnosis and treatment in women

Patients had significant changes in perivascular spaces